| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.79B | 4.71B | 4.28B | 3.99B | 3.65B |
| Gross Profit | 2.08B | 2.05B | 1.98B | 1.76B | 1.65B |
| EBITDA | 1.32B | 1.26B | 920.20M | 582.75M | 423.98M |
| Net Income | 586.82M | 618.08M | 648.48M | 417.14M | 931.57M |
Balance Sheet | |||||
| Total Assets | 6.22B | 6.18B | 5.62B | 4.60B | 4.76B |
| Cash, Cash Equivalents and Short-Term Investments | 3.41B | 3.23B | 2.85B | 2.14B | 3.19B |
| Total Debt | 2.40M | 2.63M | 3.59M | 4.55M | 0.00 |
| Total Liabilities | 3.57B | 3.45B | 3.46B | 3.10B | 3.53B |
| Stockholders Equity | 2.65B | 2.73B | 2.16B | 1.51B | 1.22B |
Cash Flow | |||||
| Free Cash Flow | 0.00 | 907.59M | 1.05B | -264.77M | 1.02B |
| Operating Cash Flow | 0.00 | 923.33M | 1.06B | -252.42M | 1.06B |
| Investing Cash Flow | 0.00 | -366.65M | -404.05M | -731.43M | 750.71M |
| Financing Cash Flow | 0.00 | -37.38M | -76.81M | -127.37M | 73.99M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥6.16B | 8.04 | ― | 1.99% | ― | ― | |
74 Outperform | ¥8.85B | 20.41 | ― | 0.47% | 19.35% | 71.74% | |
71 Outperform | ¥6.87B | 11.52 | ― | 1.18% | 6.95% | -9.62% | |
71 Outperform | ¥5.43B | 12.30 | ― | 2.50% | 4.29% | -42.71% | |
66 Neutral | ¥4.29B | 21.71 | ― | 1.54% | 28.98% | 3659.13% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
49 Neutral | ¥3.54B | -2.24 | ― | 1.17% | -21.76% | -5832.28% |